Balanced news tone
News Sentiment
PFE sentiment intelligence
Pfizer Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, +0.1% over four weeks, trend inactive, and near fair-value range.
Why is Pfizer stock sliding today?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
-1.5%
Price digesting
Trend fit
Trend inactive
0.1% over four weeks
Fair value
1.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
19
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Investing.com
Direct company coverage
Why is Pfizer stock sliding today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 20:56
- Source
- Investing.com
Benzinga
Direct company coverage
Pfizer Stock Edges Lower Monday: What's Going On? - Pfizer (NYSE:PFE)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 22 Jun 2026 14:35
- Source
- Benzinga
TechStock²
Direct company coverage
Pfizer (NYSE:PFE) stock pinned near CFO-exit selloff as investors wait for proof on growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 11:37
- Source
- TechStock²
The Motley Fool
Direct company coverage
Could Pfizer Stock Be Your Ticket to Generational Wealth?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 02:15
- Source
- The Motley Fool
Market source
Direct company coverage
Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 21 Jun 2026 15:30
- Source
- Market source
Market source
Direct company coverage
Pfizer (PFE) CFO Dave Denton to Step Down Effective August 15
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 10:52
- Source
- Market source
Market source
Direct company coverage
Pfizer (PFE) Stock Could Be 10% Undervalued After Recent Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 Jun 2026 23:07
- Source
- Market source
simplywall.st
Direct company coverage
Pfizer (PFE) Stock Could Be 10% Undervalued After CFO Exit Raises Execution Questions
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 14:28
- Source
- simplywall.st
ChartMill
Direct company coverage
PFIZER INC (PFE) Stock Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 03:07
- Source
- ChartMill
Market source
Direct company coverage
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Jun 2026 21:45
- Source
- Market source
Investing.com
Direct company coverage
Pfizer stock falls as CFO Dave Denton to step down in August
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 18 Jun 2026 11:17
- Source
- Investing.com
Stock Titan
Direct company coverage
Pfizer CFO Dave Denton exits Aug. 15; Cecile Guegan steps in
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 10:45
- Source
- Stock Titan
Seeking Alpha
Direct company coverage
Pfizer: Why I'm Still Expecting A Massive Rebound (NYSE:PFE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 19:14
- Source
- Seeking Alpha
parameter.io
Direct company coverage
Pfizer (PFE) Stock: Rises as Investors Weigh New Cancer Drug Catalyst Against Patent Risks
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 17 Jun 2026 05:06
- Source
- parameter.io
Market source
Direct company coverage
Why Pfizer’s Current Price May Be Too Cheap to Ignore
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Pfizer the Perfect Stock to Own with Kevin Warsh Heading the Fed?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
The Motley Fool
Direct company coverage
Is Pfizer Stock a "Value Trap" or a Generational Opportunity?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- The Motley Fool
Market source
Direct company coverage
Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38%
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 25 May 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
-3.15% for Pfizer stock as new share registration weighs on outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 08 May 2026 07:00
- Source
- Traders Union
parameter.io
Direct company coverage
Pfizer (PFE) Stock: Edges Higher After FDA Priority Review for Padcev in Bladder Cancer
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- parameter.io
IndexBox
Direct company coverage
Healthcare Stocks: J&J & Pfizer 2026 Outlook Amid Tech Shifts - News and Statistics
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 12 Apr 2026 07:00
- Source
- IndexBox
UnionLeader.com
Direct company coverage
Pfizer says long-awaited Lyme vaccine was effective in study
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- UnionLeader.com
Traders Union
Direct company coverage
What triggered Pfizer shares' latest price surge
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Traders Union
Traders Union
Direct company coverage
Pfizer stock: Mixed technicals and dividend focus drive a sharp downside move
- Tone
- Negative 34/100
- Event
- Capital return
- Published
- 03 Mar 2026 08:00
- Source
- Traders Union
IndexBox
Direct company coverage
Pfizer (PFE) Q4 2025 Earnings Preview: Revenue Decline Expected - News and Statistics
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 01 Feb 2026 08:00
- Source
- IndexBox
parameter.io
Direct company coverage
Pfizer (PFE) Stock: Gains Slightly After Matrix M Licensing Deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 23 Jan 2026 08:00
- Source
- parameter.io
Pharmaceutical Technology
Direct company coverage
Pfizer shares rise 3% after upping profit forecast for 2025
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 Aug 2025 07:00
- Source
- Pharmaceutical Technology
Pharmaceutical Technology
Direct company coverage
Pfizer sells 7.3% stake in Haleon for $3.3bn
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Mar 2025 07:00
- Source
- Pharmaceutical Technology
Zacks Investment Research
Direct company coverage
The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 25 Feb 2025 08:00
- Source
- Zacks Investment Research
Pharmaceutical Technology
Direct company coverage
Activist investor Starboard forges $1bn stake in Pfizer to swing profits
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 07 Oct 2024 07:00
- Source
- Pharmaceutical Technology